Driving Innovation in Addiction Research & Solutions Forward

Name: Taos Therapeutics
Address: Alamo Sq

Transforming lives with pioneering, revolutionary life sciences R&D.

San Francisco, California USA

Transforming lives with pioneering, revolutionary life sciences R&D.

San Francisco, California USA

About Taos Therapeutics

At Taos Therapeutics, our mission is to innovate and advance pharmaceuticals for the betterment of those suffering from substance use disorders.
Alcohol Use Disorder (AUD) kills ~170k Americans every year. Current FDA-approved medications (naltrexone, acamprosate, disulfiram) are poorly adopted and only modestly effective.
There is still no true adequate first-line treatment.
We are committed to developing cutting-edge therapies that address critically unmet medical needs while delivering superior ROI.
Fast to Market: streamlined 505(b)(2) regulatory path compresses timeline and costs.
Market Potential: First superior-efficacy drug could dominate an >$5B global market; and truly revolutionize treatment for a devastating disease with high morbidity and mortality as well as socioeconomic costs.
Capital Efficiency: low initial R&D spend = high leverage on investment.